Corestreet Logo

Regulus Therapeutics Inc (RGLS) Insider Trading

Total insider buys:
  • $20,113,767.22
Total insider sells:
  • $44,423,164.07
Most recent insider trade:
  • Jan. 13, 2025
Most active insider trader:
  • Isis Pharmaceuticals Inc
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 13, 2025Insider31,445$1.26Sell$39,620.70
Jan. 13, 2025VP38,547$1.26Sell$48,569.22
Jan. 13, 2025CEO115,290$1.26Sell$145,265.40
Jan. 13, 2025CFO38,716$1.26Sell$48,782.16
July 25, 2024Director4,000$1.82Buy$7,280.00
Jan. 18, 2024CFO5,468$1.19Sell$6,506.92
Jan. 18, 2024CEO14,580$1.19Sell$17,350.20
Feb. 4, 2022Insider23,314$0.23Buy$5,362.22
Jan. 26, 2022CEO100,000$0.22Buy$22,000.00
May 17, 2021CEO4,186$0.89Sell$3,725.54
May 17, 2021VP860$0.89Sell$765.40
Feb. 16, 2021CEO4,144$1.72Sell$7,127.68
Feb. 16, 2021VP828$1.72Sell$1,424.16
Dec. 4, 2020Major Shareholder4,398,602$0.62Buy$2,727,133.24
Aug. 14, 2020CEO4,245$0.60Sell$2,547.00
Aug. 14, 2020VP872$0.61Sell$531.92
May 15, 2020VP909$0.63Sell$572.67
May 15, 2020CEO4,426$0.63Sell$2,788.38
Feb. 18, 2020CEO4,324$0.83Sell$3,588.92
Feb. 18, 2020VP888$0.83Sell$737.04
Jan. 2, 2020VP2,239$0.97Sell$2,171.83
Jan. 2, 2020CEO8,345$0.97Sell$8,094.65
Nov. 14, 2019CEO5,838$0.64Sell$3,736.32
Nov. 14, 2019VP833$0.64Sell$533.12
Oct. 1, 2019VP2,346$0.68Sell$1,595.28
Oct. 1, 2019CEO8,743$0.68Sell$5,945.24
Aug. 15, 2019Insider4,375$0.55Sell$2,406.25
Aug. 15, 2019VP899$0.55Sell$494.45
July 1, 2019Insider5,783$1.31Sell$7,575.73
July 1, 2019VP2,225$1.31Sell$2,914.75
July 1, 2019CFO2,669$1.31Sell$3,496.39
May 16, 2019Insider39,352$1.22Sell$48,009.44
May 15, 2019VP6,950$1.41Sell$9,799.50
May 15, 2019CFO10,000$1.41Sell$14,100.00
May 7, 2019Major Shareholder1,136,704$1.08Buy$1,227,640.32
May 7, 2019Director29,630$1.08Buy$32,000.40
May 7, 2019CEO33,194$1.08Buy$35,849.52
April 1, 2019VP2,710$0.98Sell$2,655.80
April 1, 2019CEO5,842$0.98Sell$5,725.16
April 1, 2019CFO3,253$0.98Sell$3,187.94
Dec. 28, 2018Director50,000$1.09Buy$54,500.00
Dec. 27, 2018Director116,401$0.97Buy$112,908.97
Nov. 16, 2018Director7,100$1.41Buy$10,011.00
July 25, 2017Insider219,780$0.91Buy$199,999.80
July 25, 2017CFO54,945$0.91Buy$49,999.95
July 25, 2017Director274,725$0.91Buy$249,999.75
March 22, 2017Director500,000$1.22Buy$610,000.00
March 7, 2017Director250,000$1.15Buy$287,500.00
March 3, 2016COO10,000$7.19Buy$71,900.00
Feb. 23, 2016Major Shareholder1,000,000$7.18Sell$7,180,000.00
First«1 of 3»Last

  • Insiders are both buying and selling Regulus Therapeutics Inc stock.

  • The insider traders at Regulus Therapeutics Inc are: Isis Pharmaceuticals Inc, Joseph P Hagan, Alnylam Pharmaceuticals, Inc., Christopher Ray Aker, Kleanthis G Xanthopoulos, William H Rastetter, Daniel R Chevallard, Neil W Gibson, Neil Gibson, Stelios Papadopoulos, Crispina Calsada, Kathryn J Collier, Paul Edward Walker, Peter J Barris, Preston Klassen, Sanofi, Stanley T Crooke, Denis Drygin, Kleanthis Xanthopoulos, Bruce L A Carter, and Pascale Witz

  • The most active insider trader at Regulus Therapeutics Inc is Isis Pharmaceuticals Inc with 34 trades.

  • Isis Pharmaceuticals Inc has sold the most Regulus Therapeutics Inc stock with a total value of $28,417,089.94.

  • Sanofi has bought the most Regulus Therapeutics Inc stock with a total value of $19,999,985.20.

  • The most recent insider trade for Regulus Therapeutics Inc was on Jan. 13, 2025.

  • The single biggest insider buy for Regulus Therapeutics Inc was from Sanofi with a total value of $9,999,992.60 on Feb. 4, 2014.

  • The single biggest insider sell for Regulus Therapeutics Inc was from Isis Pharmaceuticals Inc with a total value of $20,393,811.34 on Nov. 3, 2014.